Work

Safety and Efficacy Results from a Phase II Trial of De-Escalated Ptcy and Ruxolitinib for GVHD Prophylaxis in Older Patients Undergoing Reduced Intensity Conditioning Allogeneic HCT

Year: 2026

Type: article

Study design: Clinical Trial

Source: Transplantation and Cellular Therapy

DOI: 10.1016/j.jtct.2025.12.958

Authors: Sameem Abedin, Lyndsey Runaas, Nirav N. Shah, Marcelo C. Pasquini, Walter Longo, Fateeha Furqan, William R. Drobyski, Xue-Zhong Yu, Mehdi Hamadani

Institutions: Medical College of Wisconsin, Cleveland Clinic, The University of Texas MD Anderson Cancer Center

Language: English

Topic: Hematopoietic Stem Cell Transplantation

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7127325687

FWCI:

Cites:

Cited by:

Related to: